The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global CRISPER-associated Nucleases Market Research Report 2025
Synopsis
A programmable tools used for CRISPER (clusters of regularly interspaced short palindromic repeats), which could mediate targeted DNA or RNA cleavage. These sepecific endonuclease drives targeted gene disruption through nonhomologous end joining (NHEJ) or precise gene editing through template-dependent homology-directed repair (HDR).
The global CRISPER-associated Nucleases market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for CRISPER-associated Nucleases is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for CRISPER-associated Nucleases is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of CRISPER-associated Nucleases include The Odin, Origene, Amsbio, Thermo Fisher Scientific, Merck, Boai Nky Medical Holdings Ltd, Biocompare, BioLabs, Inc. and Inscripta, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for CRISPER-associated Nucleases, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CRISPER-associated Nucleases.
Report Scope
The CRISPER-associated Nucleases market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global CRISPER-associated Nucleases market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the CRISPER-associated Nucleases manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
The Odin
Origene
Amsbio
Thermo Fisher Scientific
Merck
Boai Nky Medical Holdings Ltd
Biocompare
BioLabs, Inc.
Inscripta
Sherlock Biosciences
Editas
CRISPR Therapeutics
Synthego
Addgene
IDT (Integrated DNA Technologies)
Horizon Discovery
ToolGen
GenScript
New England Biolabs (NEB)
Segment by Type
CRISPER-associated Protein 9 (Cas 9)
Cpf 1
CRISPER-associated Protein 13 (Cas 13)
Segment by Application
DNA Editing
RNA Editing
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of CRISPER-associated Nucleases manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of CRISPER-associated Nucleases in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
A programmable tools used for CRISPER (clusters of regularly interspaced short palindromic repeats), which could mediate targeted DNA or RNA cleavage. These sepecific endonuclease drives targeted gene disruption through nonhomologous end joining (NHEJ) or precise gene editing through template-dependent homology-directed repair (HDR).
The global CRISPER-associated Nucleases market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for CRISPER-associated Nucleases is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for CRISPER-associated Nucleases is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of CRISPER-associated Nucleases include The Odin, Origene, Amsbio, Thermo Fisher Scientific, Merck, Boai Nky Medical Holdings Ltd, Biocompare, BioLabs, Inc. and Inscripta, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for CRISPER-associated Nucleases, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CRISPER-associated Nucleases.
Report Scope
The CRISPER-associated Nucleases market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global CRISPER-associated Nucleases market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the CRISPER-associated Nucleases manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
The Odin
Origene
Amsbio
Thermo Fisher Scientific
Merck
Boai Nky Medical Holdings Ltd
Biocompare
BioLabs, Inc.
Inscripta
Sherlock Biosciences
Editas
CRISPR Therapeutics
Synthego
Addgene
IDT (Integrated DNA Technologies)
Horizon Discovery
ToolGen
GenScript
New England Biolabs (NEB)
Segment by Type
CRISPER-associated Protein 9 (Cas 9)
Cpf 1
CRISPER-associated Protein 13 (Cas 13)
Segment by Application
DNA Editing
RNA Editing
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of CRISPER-associated Nucleases manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of CRISPER-associated Nucleases in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 CRISPER-associated Nucleases Market Overview
1.1 Product Overview and Scope of CRISPER-associated Nucleases
1.2 CRISPER-associated Nucleases Segment by Type
1.2.1 Global CRISPER-associated Nucleases Market Value Comparison by Type (2024-2030)
1.2.2 CRISPER-associated Protein 9 (Cas 9)
1.2.3 Cpf 1
1.2.4 CRISPER-associated Protein 13 (Cas 13)
1.3 CRISPER-associated Nucleases Segment by Application
1.3.1 Global CRISPER-associated Nucleases Market Value by Application: (2024-2030)
1.3.2 DNA Editing
1.3.3 RNA Editing
1.4 Global CRISPER-associated Nucleases Market Size Estimates and Forecasts
1.4.1 Global CRISPER-associated Nucleases Revenue 2019-2030
1.4.2 Global CRISPER-associated Nucleases Sales 2019-2030
1.4.3 Global CRISPER-associated Nucleases Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 CRISPER-associated Nucleases Market Competition by Manufacturers
2.1 Global CRISPER-associated Nucleases Sales Market Share by Manufacturers (2019-2024)
2.2 Global CRISPER-associated Nucleases Revenue Market Share by Manufacturers (2019-2024)
2.3 Global CRISPER-associated Nucleases Average Price by Manufacturers (2019-2024)
2.4 Global CRISPER-associated Nucleases Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of CRISPER-associated Nucleases, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of CRISPER-associated Nucleases, Product Type & Application
2.7 CRISPER-associated Nucleases Market Competitive Situation and Trends
2.7.1 CRISPER-associated Nucleases Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest CRISPER-associated Nucleases Players Market Share by Revenue
2.7.3 Global CRISPER-associated Nucleases Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 CRISPER-associated Nucleases Retrospective Market Scenario by Region
3.1 Global CRISPER-associated Nucleases Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global CRISPER-associated Nucleases Global CRISPER-associated Nucleases Sales by Region: 2019-2030
3.2.1 Global CRISPER-associated Nucleases Sales by Region: 2019-2024
3.2.2 Global CRISPER-associated Nucleases Sales by Region: 2025-2030
3.3 Global CRISPER-associated Nucleases Global CRISPER-associated Nucleases Revenue by Region: 2019-2030
3.3.1 Global CRISPER-associated Nucleases Revenue by Region: 2019-2024
3.3.2 Global CRISPER-associated Nucleases Revenue by Region: 2025-2030
3.4 North America CRISPER-associated Nucleases Market Facts & Figures by Country
3.4.1 North America CRISPER-associated Nucleases Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America CRISPER-associated Nucleases Sales by Country (2019-2030)
3.4.3 North America CRISPER-associated Nucleases Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe CRISPER-associated Nucleases Market Facts & Figures by Country
3.5.1 Europe CRISPER-associated Nucleases Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe CRISPER-associated Nucleases Sales by Country (2019-2030)
3.5.3 Europe CRISPER-associated Nucleases Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific CRISPER-associated Nucleases Market Facts & Figures by Country
3.6.1 Asia Pacific CRISPER-associated Nucleases Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific CRISPER-associated Nucleases Sales by Country (2019-2030)
3.6.3 Asia Pacific CRISPER-associated Nucleases Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America CRISPER-associated Nucleases Market Facts & Figures by Country
3.7.1 Latin America CRISPER-associated Nucleases Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America CRISPER-associated Nucleases Sales by Country (2019-2030)
3.7.3 Latin America CRISPER-associated Nucleases Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa CRISPER-associated Nucleases Market Facts & Figures by Country
3.8.1 Middle East and Africa CRISPER-associated Nucleases Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa CRISPER-associated Nucleases Sales by Country (2019-2030)
3.8.3 Middle East and Africa CRISPER-associated Nucleases Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global CRISPER-associated Nucleases Sales by Type (2019-2030)
4.1.1 Global CRISPER-associated Nucleases Sales by Type (2019-2024)
4.1.2 Global CRISPER-associated Nucleases Sales by Type (2025-2030)
4.1.3 Global CRISPER-associated Nucleases Sales Market Share by Type (2019-2030)
4.2 Global CRISPER-associated Nucleases Revenue by Type (2019-2030)
4.2.1 Global CRISPER-associated Nucleases Revenue by Type (2019-2024)
4.2.2 Global CRISPER-associated Nucleases Revenue by Type (2025-2030)
4.2.3 Global CRISPER-associated Nucleases Revenue Market Share by Type (2019-2030)
4.3 Global CRISPER-associated Nucleases Price by Type (2019-2030)
5 Segment by Application
5.1 Global CRISPER-associated Nucleases Sales by Application (2019-2030)
5.1.1 Global CRISPER-associated Nucleases Sales by Application (2019-2024)
5.1.2 Global CRISPER-associated Nucleases Sales by Application (2025-2030)
5.1.3 Global CRISPER-associated Nucleases Sales Market Share by Application (2019-2030)
5.2 Global CRISPER-associated Nucleases Revenue by Application (2019-2030)
5.2.1 Global CRISPER-associated Nucleases Revenue by Application (2019-2024)
5.2.2 Global CRISPER-associated Nucleases Revenue by Application (2025-2030)
5.2.3 Global CRISPER-associated Nucleases Revenue Market Share by Application (2019-2030)
5.3 Global CRISPER-associated Nucleases Price by Application (2019-2030)
6 Key Companies Profiled
6.1 The Odin
6.1.1 The Odin Corporation Information
6.1.2 The Odin Description and Business Overview
6.1.3 The Odin CRISPER-associated Nucleases Sales, Revenue and Gross Margin (2019-2024)
6.1.4 The Odin CRISPER-associated Nucleases Product Portfolio
6.1.5 The Odin Recent Developments/Updates
6.2 Origene
6.2.1 Origene Corporation Information
6.2.2 Origene Description and Business Overview
6.2.3 Origene CRISPER-associated Nucleases Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Origene CRISPER-associated Nucleases Product Portfolio
6.2.5 Origene Recent Developments/Updates
6.3 Amsbio
6.3.1 Amsbio Corporation Information
6.3.2 Amsbio Description and Business Overview
6.3.3 Amsbio CRISPER-associated Nucleases Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Amsbio CRISPER-associated Nucleases Product Portfolio
6.3.5 Amsbio Recent Developments/Updates
6.4 Thermo Fisher Scientific
6.4.1 Thermo Fisher Scientific Corporation Information
6.4.2 Thermo Fisher Scientific Description and Business Overview
6.4.3 Thermo Fisher Scientific CRISPER-associated Nucleases Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Thermo Fisher Scientific CRISPER-associated Nucleases Product Portfolio
6.4.5 Thermo Fisher Scientific Recent Developments/Updates
6.5 Merck
6.5.1 Merck Corporation Information
6.5.2 Merck Description and Business Overview
6.5.3 Merck CRISPER-associated Nucleases Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Merck CRISPER-associated Nucleases Product Portfolio
6.5.5 Merck Recent Developments/Updates
6.6 Boai Nky Medical Holdings Ltd
6.6.1 Boai Nky Medical Holdings Ltd Corporation Information
6.6.2 Boai Nky Medical Holdings Ltd Description and Business Overview
6.6.3 Boai Nky Medical Holdings Ltd CRISPER-associated Nucleases Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Boai Nky Medical Holdings Ltd CRISPER-associated Nucleases Product Portfolio
6.6.5 Boai Nky Medical Holdings Ltd Recent Developments/Updates
6.7 Biocompare
6.6.1 Biocompare Corporation Information
6.6.2 Biocompare Description and Business Overview
6.6.3 Biocompare CRISPER-associated Nucleases Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Biocompare CRISPER-associated Nucleases Product Portfolio
6.7.5 Biocompare Recent Developments/Updates
6.8 BioLabs, Inc.
6.8.1 BioLabs, Inc. Corporation Information
6.8.2 BioLabs, Inc. Description and Business Overview
6.8.3 BioLabs, Inc. CRISPER-associated Nucleases Sales, Revenue and Gross Margin (2019-2024)
6.8.4 BioLabs, Inc. CRISPER-associated Nucleases Product Portfolio
6.8.5 BioLabs, Inc. Recent Developments/Updates
6.9 Inscripta
6.9.1 Inscripta Corporation Information
6.9.2 Inscripta Description and Business Overview
6.9.3 Inscripta CRISPER-associated Nucleases Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Inscripta CRISPER-associated Nucleases Product Portfolio
6.9.5 Inscripta Recent Developments/Updates
6.10 Sherlock Biosciences
6.10.1 Sherlock Biosciences Corporation Information
6.10.2 Sherlock Biosciences Description and Business Overview
6.10.3 Sherlock Biosciences CRISPER-associated Nucleases Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Sherlock Biosciences CRISPER-associated Nucleases Product Portfolio
6.10.5 Sherlock Biosciences Recent Developments/Updates
6.11 Editas
6.11.1 Editas Corporation Information
6.11.2 Editas CRISPER-associated Nucleases Description and Business Overview
6.11.3 Editas CRISPER-associated Nucleases Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Editas CRISPER-associated Nucleases Product Portfolio
6.11.5 Editas Recent Developments/Updates
6.12 CRISPR Therapeutics
6.12.1 CRISPR Therapeutics Corporation Information
6.12.2 CRISPR Therapeutics CRISPER-associated Nucleases Description and Business Overview
6.12.3 CRISPR Therapeutics CRISPER-associated Nucleases Sales, Revenue and Gross Margin (2019-2024)
6.12.4 CRISPR Therapeutics CRISPER-associated Nucleases Product Portfolio
6.12.5 CRISPR Therapeutics Recent Developments/Updates
6.13 Synthego
6.13.1 Synthego Corporation Information
6.13.2 Synthego CRISPER-associated Nucleases Description and Business Overview
6.13.3 Synthego CRISPER-associated Nucleases Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Synthego CRISPER-associated Nucleases Product Portfolio
6.13.5 Synthego Recent Developments/Updates
6.14 Addgene
6.14.1 Addgene Corporation Information
6.14.2 Addgene CRISPER-associated Nucleases Description and Business Overview
6.14.3 Addgene CRISPER-associated Nucleases Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Addgene CRISPER-associated Nucleases Product Portfolio
6.14.5 Addgene Recent Developments/Updates
6.15 IDT (Integrated DNA Technologies)
6.15.1 IDT (Integrated DNA Technologies) Corporation Information
6.15.2 IDT (Integrated DNA Technologies) CRISPER-associated Nucleases Description and Business Overview
6.15.3 IDT (Integrated DNA Technologies) CRISPER-associated Nucleases Sales, Revenue and Gross Margin (2019-2024)
6.15.4 IDT (Integrated DNA Technologies) CRISPER-associated Nucleases Product Portfolio
6.15.5 IDT (Integrated DNA Technologies) Recent Developments/Updates
6.16 Horizon Discovery
6.16.1 Horizon Discovery Corporation Information
6.16.2 Horizon Discovery CRISPER-associated Nucleases Description and Business Overview
6.16.3 Horizon Discovery CRISPER-associated Nucleases Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Horizon Discovery CRISPER-associated Nucleases Product Portfolio
6.16.5 Horizon Discovery Recent Developments/Updates
6.17 ToolGen
6.17.1 ToolGen Corporation Information
6.17.2 ToolGen CRISPER-associated Nucleases Description and Business Overview
6.17.3 ToolGen CRISPER-associated Nucleases Sales, Revenue and Gross Margin (2019-2024)
6.17.4 ToolGen CRISPER-associated Nucleases Product Portfolio
6.17.5 ToolGen Recent Developments/Updates
6.18 GenScript
6.18.1 GenScript Corporation Information
6.18.2 GenScript CRISPER-associated Nucleases Description and Business Overview
6.18.3 GenScript CRISPER-associated Nucleases Sales, Revenue and Gross Margin (2019-2024)
6.18.4 GenScript CRISPER-associated Nucleases Product Portfolio
6.18.5 GenScript Recent Developments/Updates
6.19 New England Biolabs (NEB)
6.19.1 New England Biolabs (NEB) Corporation Information
6.19.2 New England Biolabs (NEB) CRISPER-associated Nucleases Description and Business Overview
6.19.3 New England Biolabs (NEB) CRISPER-associated Nucleases Sales, Revenue and Gross Margin (2019-2024)
6.19.4 New England Biolabs (NEB) CRISPER-associated Nucleases Product Portfolio
6.19.5 New England Biolabs (NEB) Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 CRISPER-associated Nucleases Industry Chain Analysis
7.2 CRISPER-associated Nucleases Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 CRISPER-associated Nucleases Production Mode & Process
7.4 CRISPER-associated Nucleases Sales and Marketing
7.4.1 CRISPER-associated Nucleases Sales Channels
7.4.2 CRISPER-associated Nucleases Distributors
7.5 CRISPER-associated Nucleases Customers
8 CRISPER-associated Nucleases Market Dynamics
8.1 CRISPER-associated Nucleases Industry Trends
8.2 CRISPER-associated Nucleases Market Drivers
8.3 CRISPER-associated Nucleases Market Challenges
8.4 CRISPER-associated Nucleases Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global CRISPER-associated Nucleases Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global CRISPER-associated Nucleases Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global CRISPER-associated Nucleases Market Competitive Situation by Manufacturers in 2023
Table 4. Global CRISPER-associated Nucleases Sales (Kg) of Key Manufacturers (2019-2024)
Table 5. Global CRISPER-associated Nucleases Sales Market Share by Manufacturers (2019-2024)
Table 6. Global CRISPER-associated Nucleases Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global CRISPER-associated Nucleases Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market CRISPER-associated Nucleases Average Price (US$/Kg) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of CRISPER-associated Nucleases, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of CRISPER-associated Nucleases, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of CRISPER-associated Nucleases, Product Type & Application
Table 12. Global Key Manufacturers of CRISPER-associated Nucleases, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global CRISPER-associated Nucleases by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CRISPER-associated Nucleases as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global CRISPER-associated Nucleases Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global CRISPER-associated Nucleases Sales by Region (2019-2024) & (Kg)
Table 18. Global CRISPER-associated Nucleases Sales Market Share by Region (2019-2024)
Table 19. Global CRISPER-associated Nucleases Sales by Region (2025-2030) & (Kg)
Table 20. Global CRISPER-associated Nucleases Sales Market Share by Region (2025-2030)
Table 21. Global CRISPER-associated Nucleases Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global CRISPER-associated Nucleases Revenue Market Share by Region (2019-2024)
Table 23. Global CRISPER-associated Nucleases Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global CRISPER-associated Nucleases Revenue Market Share by Region (2025-2030)
Table 25. North America CRISPER-associated Nucleases Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America CRISPER-associated Nucleases Sales by Country (2019-2024) & (Kg)
Table 27. North America CRISPER-associated Nucleases Sales by Country (2025-2030) & (Kg)
Table 28. North America CRISPER-associated Nucleases Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America CRISPER-associated Nucleases Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe CRISPER-associated Nucleases Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe CRISPER-associated Nucleases Sales by Country (2019-2024) & (Kg)
Table 32. Europe CRISPER-associated Nucleases Sales by Country (2025-2030) & (Kg)
Table 33. Europe CRISPER-associated Nucleases Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe CRISPER-associated Nucleases Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific CRISPER-associated Nucleases Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific CRISPER-associated Nucleases Sales by Region (2019-2024) & (Kg)
Table 37. Asia Pacific CRISPER-associated Nucleases Sales by Region (2025-2030) & (Kg)
Table 38. Asia Pacific CRISPER-associated Nucleases Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific CRISPER-associated Nucleases Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America CRISPER-associated Nucleases Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America CRISPER-associated Nucleases Sales by Country (2019-2024) & (Kg)
Table 42. Latin America CRISPER-associated Nucleases Sales by Country (2025-2030) & (Kg)
Table 43. Latin America CRISPER-associated Nucleases Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America CRISPER-associated Nucleases Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa CRISPER-associated Nucleases Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa CRISPER-associated Nucleases Sales by Country (2019-2024) & (Kg)
Table 47. Middle East & Africa CRISPER-associated Nucleases Sales by Country (2025-2030) & (Kg)
Table 48. Middle East & Africa CRISPER-associated Nucleases Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa CRISPER-associated Nucleases Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global CRISPER-associated Nucleases Sales (Kg) by Type (2019-2024)
Table 51. Global CRISPER-associated Nucleases Sales (Kg) by Type (2025-2030)
Table 52. Global CRISPER-associated Nucleases Sales Market Share by Type (2019-2024)
Table 53. Global CRISPER-associated Nucleases Sales Market Share by Type (2025-2030)
Table 54. Global CRISPER-associated Nucleases Revenue (US$ Million) by Type (2019-2024)
Table 55. Global CRISPER-associated Nucleases Revenue (US$ Million) by Type (2025-2030)
Table 56. Global CRISPER-associated Nucleases Revenue Market Share by Type (2019-2024)
Table 57. Global CRISPER-associated Nucleases Revenue Market Share by Type (2025-2030)
Table 58. Global CRISPER-associated Nucleases Price (US$/Kg) by Type (2019-2024)
Table 59. Global CRISPER-associated Nucleases Price (US$/Kg) by Type (2025-2030)
Table 60. Global CRISPER-associated Nucleases Sales (Kg) by Application (2019-2024)
Table 61. Global CRISPER-associated Nucleases Sales (Kg) by Application (2025-2030)
Table 62. Global CRISPER-associated Nucleases Sales Market Share by Application (2019-2024)
Table 63. Global CRISPER-associated Nucleases Sales Market Share by Application (2025-2030)
Table 64. Global CRISPER-associated Nucleases Revenue (US$ Million) by Application (2019-2024)
Table 65. Global CRISPER-associated Nucleases Revenue (US$ Million) by Application (2025-2030)
Table 66. Global CRISPER-associated Nucleases Revenue Market Share by Application (2019-2024)
Table 67. Global CRISPER-associated Nucleases Revenue Market Share by Application (2025-2030)
Table 68. Global CRISPER-associated Nucleases Price (US$/Kg) by Application (2019-2024)
Table 69. Global CRISPER-associated Nucleases Price (US$/Kg) by Application (2025-2030)
Table 70. The Odin Corporation Information
Table 71. The Odin Description and Business Overview
Table 72. The Odin CRISPER-associated Nucleases Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 73. The Odin CRISPER-associated Nucleases Product
Table 74. The Odin Recent Developments/Updates
Table 75. Origene Corporation Information
Table 76. Origene Description and Business Overview
Table 77. Origene CRISPER-associated Nucleases Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 78. Origene CRISPER-associated Nucleases Product
Table 79. Origene Recent Developments/Updates
Table 80. Amsbio Corporation Information
Table 81. Amsbio Description and Business Overview
Table 82. Amsbio CRISPER-associated Nucleases Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 83. Amsbio CRISPER-associated Nucleases Product
Table 84. Amsbio Recent Developments/Updates
Table 85. Thermo Fisher Scientific Corporation Information
Table 86. Thermo Fisher Scientific Description and Business Overview
Table 87. Thermo Fisher Scientific CRISPER-associated Nucleases Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 88. Thermo Fisher Scientific CRISPER-associated Nucleases Product
Table 89. Thermo Fisher Scientific Recent Developments/Updates
Table 90. Merck Corporation Information
Table 91. Merck Description and Business Overview
Table 92. Merck CRISPER-associated Nucleases Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 93. Merck CRISPER-associated Nucleases Product
Table 94. Merck Recent Developments/Updates
Table 95. Boai Nky Medical Holdings Ltd Corporation Information
Table 96. Boai Nky Medical Holdings Ltd Description and Business Overview
Table 97. Boai Nky Medical Holdings Ltd CRISPER-associated Nucleases Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 98. Boai Nky Medical Holdings Ltd CRISPER-associated Nucleases Product
Table 99. Boai Nky Medical Holdings Ltd Recent Developments/Updates
Table 100. Biocompare Corporation Information
Table 101. Biocompare Description and Business Overview
Table 102. Biocompare CRISPER-associated Nucleases Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 103. Biocompare CRISPER-associated Nucleases Product
Table 104. Biocompare Recent Developments/Updates
Table 105. BioLabs, Inc. Corporation Information
Table 106. BioLabs, Inc. Description and Business Overview
Table 107. BioLabs, Inc. CRISPER-associated Nucleases Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 108. BioLabs, Inc. CRISPER-associated Nucleases Product
Table 109. BioLabs, Inc. Recent Developments/Updates
Table 110. Inscripta Corporation Information
Table 111. Inscripta Description and Business Overview
Table 112. Inscripta CRISPER-associated Nucleases Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 113. Inscripta CRISPER-associated Nucleases Product
Table 114. Inscripta Recent Developments/Updates
Table 115. Sherlock Biosciences Corporation Information
Table 116. Sherlock Biosciences Description and Business Overview
Table 117. Sherlock Biosciences CRISPER-associated Nucleases Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 118. Sherlock Biosciences CRISPER-associated Nucleases Product
Table 119. Sherlock Biosciences Recent Developments/Updates
Table 120. Editas Corporation Information
Table 121. Editas Description and Business Overview
Table 122. Editas CRISPER-associated Nucleases Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 123. Editas CRISPER-associated Nucleases Product
Table 124. Editas Recent Developments/Updates
Table 125. CRISPR Therapeutics Corporation Information
Table 126. CRISPR Therapeutics Description and Business Overview
Table 127. CRISPR Therapeutics CRISPER-associated Nucleases Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 128. CRISPR Therapeutics CRISPER-associated Nucleases Product
Table 129. CRISPR Therapeutics Recent Developments/Updates
Table 130. Synthego Corporation Information
Table 131. Synthego Description and Business Overview
Table 132. Synthego CRISPER-associated Nucleases Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 133. Synthego CRISPER-associated Nucleases Product
Table 134. Synthego Recent Developments/Updates
Table 135. Addgene Corporation Information
Table 136. Addgene Description and Business Overview
Table 137. Addgene CRISPER-associated Nucleases Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 138. Addgene CRISPER-associated Nucleases Product
Table 139. Addgene Recent Developments/Updates
Table 140. IDT (Integrated DNA Technologies) Corporation Information
Table 141. IDT (Integrated DNA Technologies) Description and Business Overview
Table 142. IDT (Integrated DNA Technologies) CRISPER-associated Nucleases Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 143. IDT (Integrated DNA Technologies) CRISPER-associated Nucleases Product
Table 144. IDT (Integrated DNA Technologies) Recent Developments/Updates
Table 145. Horizon Discovery Corporation Information
Table 146. Horizon Discovery Description and Business Overview
Table 147. Horizon Discovery CRISPER-associated Nucleases Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 148. Horizon Discovery CRISPER-associated Nucleases Product
Table 149. Horizon Discovery Recent Developments/Updates
Table 150. ToolGen Corporation Information
Table 151. ToolGen Description and Business Overview
Table 152. ToolGen CRISPER-associated Nucleases Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 153. ToolGen CRISPER-associated Nucleases Product
Table 154. ToolGen Recent Developments/Updates
Table 155. GenScript Corporation Information
Table 156. GenScript Description and Business Overview
Table 157. GenScript CRISPER-associated Nucleases Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 158. GenScript CRISPER-associated Nucleases Product
Table 159. GenScript Recent Developments/Updates
Table 160. New England Biolabs (NEB) Corporation Information
Table 161. New England Biolabs (NEB) Description and Business Overview
Table 162. New England Biolabs (NEB) CRISPER-associated Nucleases Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 163. New England Biolabs (NEB) CRISPER-associated Nucleases Product
Table 164. New England Biolabs (NEB) Recent Developments/Updates
Table 165. Key Raw Materials Lists
Table 166. Raw Materials Key Suppliers Lists
Table 167. CRISPER-associated Nucleases Distributors List
Table 168. CRISPER-associated Nucleases Customers List
Table 169. CRISPER-associated Nucleases Market Trends
Table 170. CRISPER-associated Nucleases Market Drivers
Table 171. CRISPER-associated Nucleases Market Challenges
Table 172. CRISPER-associated Nucleases Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of CRISPER-associated Nucleases
Figure 2. Global CRISPER-associated Nucleases Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global CRISPER-associated Nucleases Market Share by Type in 2023 & 2030
Figure 4. CRISPER-associated Protein 9 (Cas 9) Product Picture
Figure 5. Cpf 1 Product Picture
Figure 6. CRISPER-associated Protein 13 (Cas 13) Product Picture
Figure 7. Global CRISPER-associated Nucleases Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global CRISPER-associated Nucleases Market Share by Application in 2023 & 2030
Figure 9. DNA Editing
Figure 10. RNA Editing
Figure 11. Global CRISPER-associated Nucleases Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global CRISPER-associated Nucleases Market Size (2019-2030) & (US$ Million)
Figure 13. Global CRISPER-associated Nucleases Sales (2019-2030) & (Kg)
Figure 14. Global CRISPER-associated Nucleases Average Price (US$/Kg) & (2019-2030)
Figure 15. CRISPER-associated Nucleases Report Years Considered
Figure 16. CRISPER-associated Nucleases Sales Share by Manufacturers in 2023
Figure 17. Global CRISPER-associated Nucleases Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest CRISPER-associated Nucleases Players: Market Share by Revenue in 2023
Figure 19. CRISPER-associated Nucleases Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global CRISPER-associated Nucleases Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America CRISPER-associated Nucleases Sales Market Share by Country (2019-2030)
Figure 22. North America CRISPER-associated Nucleases Revenue Market Share by Country (2019-2030)
Figure 23. U.S. CRISPER-associated Nucleases Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada CRISPER-associated Nucleases Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe CRISPER-associated Nucleases Sales Market Share by Country (2019-2030)
Figure 26. Europe CRISPER-associated Nucleases Revenue Market Share by Country (2019-2030)
Figure 27. Germany CRISPER-associated Nucleases Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France CRISPER-associated Nucleases Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. CRISPER-associated Nucleases Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy CRISPER-associated Nucleases Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia CRISPER-associated Nucleases Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific CRISPER-associated Nucleases Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific CRISPER-associated Nucleases Revenue Market Share by Region (2019-2030)
Figure 34. China CRISPER-associated Nucleases Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan CRISPER-associated Nucleases Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea CRISPER-associated Nucleases Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India CRISPER-associated Nucleases Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia CRISPER-associated Nucleases Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Taiwan CRISPER-associated Nucleases Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia CRISPER-associated Nucleases Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand CRISPER-associated Nucleases Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia CRISPER-associated Nucleases Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Philippines CRISPER-associated Nucleases Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America CRISPER-associated Nucleases Sales Market Share by Country (2019-2030)
Figure 45. Latin America CRISPER-associated Nucleases Revenue Market Share by Country (2019-2030)
Figure 46. Mexico CRISPER-associated Nucleases Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil CRISPER-associated Nucleases Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina CRISPER-associated Nucleases Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa CRISPER-associated Nucleases Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa CRISPER-associated Nucleases Revenue Market Share by Country (2019-2030)
Figure 51. Turkey CRISPER-associated Nucleases Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia CRISPER-associated Nucleases Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. UAE CRISPER-associated Nucleases Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of CRISPER-associated Nucleases by Type (2019-2030)
Figure 55. Global Revenue Market Share of CRISPER-associated Nucleases by Type (2019-2030)
Figure 56. Global CRISPER-associated Nucleases Price (US$/Kg) by Type (2019-2030)
Figure 57. Global Sales Market Share of CRISPER-associated Nucleases by Application (2019-2030)
Figure 58. Global Revenue Market Share of CRISPER-associated Nucleases by Application (2019-2030)
Figure 59. Global CRISPER-associated Nucleases Price (US$/Kg) by Application (2019-2030)
Figure 60. CRISPER-associated Nucleases Value Chain
Figure 61. CRISPER-associated Nucleases Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
